Addex Therapeutics Ltd Cash Flow Quality Index

Latest as of June 2024: -0.21x

Addex Therapeutics Ltd cash flow quality index. Addex Therapeutics Ltd (ADXN) has a Cash Flow Quality Index of -0.21x as of June 2024. Operating cash flow of $-2.76 Million is below net income of $12.88 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Addex Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.21x

Operating CF / Net Income

Operating Cash Flow

$-2.76 Million

USD

Net Income

$12.88 Million

USD

Data as of

Jun 2024

Most recent filing

Cash Flow Quality Index of Addex Therapeutics Ltd (2024–2024)

Cash flow quality index of Addex Therapeutics Ltd from 2024 to 2024. Historical Cash Flow Quality Index for Addex Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Addex Therapeutics Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Addex Therapeutics Ltd Cash Flow Quality Index by Year (2024–2024)

Addex Therapeutics Ltd cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Addex Therapeutics Ltd. For the full cash flow conversion analysis, see Addex Therapeutics Ltd (ADXN) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2024	-0.76x	$-5.37 Million	$7.06 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.